Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000542843 | SCV000634642 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2023-09-22 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 3 of the CEP290 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). This variant is present in population databases (rs758593134, gnomAD 0.001%). Disruption of this splice site has been observed in individual(s) with Leber congenital amaurosis (PMID: 16909394; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 461777). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Molecular Genetics Laboratory, |
RCV001199655 | SCV001162443 | pathogenic | Retinitis pigmentosa | 2020-01-09 | criteria provided, single submitter | research | |
Ce |
RCV001091342 | SCV001247310 | pathogenic | not provided | 2018-02-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV002289749 | SCV002579306 | pathogenic | Meckel syndrome, type 4 | 2021-10-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002497107 | SCV002779160 | likely pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Department of Clinical Genetics, |
RCV000787558 | SCV000926534 | likely pathogenic | Leber congenital amaurosis | 2018-04-01 | no assertion criteria provided | research | |
Natera, |
RCV000787558 | SCV002094945 | pathogenic | Leber congenital amaurosis | 2020-07-09 | no assertion criteria provided | clinical testing |